Diosmetin Protects against Cardiac Hypertrophy via p62/Keap1/Nrf2 Signaling Pathway.

MLA

Guo, Yingying, et al. “Diosmetin Protects against Cardiac Hypertrophy via P62/Keap1/Nrf2 Signaling Pathway.” Oxidative Medicine & Cellular Longevity, Feb. 2022, pp. 1–14. EBSCOhost, https://doi.org/10.1155/2022/8367997.

APA

Guo, Y., Li, D., Cen, X., Qiu, H., Ma, Y., Liu, Y., Huang, S., Liu, L., Xu, M., & Tang, Q.-Z. (2022). Diosmetin Protects against Cardiac Hypertrophy via p62/Keap1/Nrf2 Signaling Pathway. Oxidative Medicine & Cellular Longevity, 1–14. https://doi.org/10.1155/2022/8367997

Chicago

Guo, Yingying, Dan Li, Xian-feng Cen, Hong-liang Qiu, Yu-lan Ma, Yi Liu, Si-hui Huang, Li-bo Liu, Man Xu, and Qi-Zhu Tang. 2022. “Diosmetin Protects against Cardiac Hypertrophy via P62/Keap1/Nrf2 Signaling Pathway.” Oxidative Medicine & Cellular Longevity, February, 1–14. doi:10.1155/2022/8367997.